Dr. Frank Pun is the Head of the Hong Kong Office at Insilico Medicine. Frank received his Ph.D. in biochemistry from the Hong Kong University of Science and Technology in 2010. He served as a visiting scholar, leading a team dedicated to studying human CNS diseases and cancer for several years. In 2019, he also obtained an MBA from Rutgers Business School in the United States. 

Throughout his career, Frank has made significant contributions to target discovery, publishing numerous impactful papers in the field. He is recognized as a key opinion leader in AI-powered therapeutic target discovery.